Irritable Bowel Syndrome.
Upon completion of this session, the participant should be able to: EBM, COMP
- Appraise possible etiologies for Irritable Bowel Syndrome.
- Select and utilize diagnostic criteria to identify IBS, based on the current medical evidence and expert recommendations.
- Use the current medical literature to assess and screen for other conditions that can present with similar IBS symptoms.
- Detect “red flag” signs and symptoms that should make one question the diagnosis of IBS.
- Formulate an EBM diagnostic evaluation for patients with signs and symptoms of IBS.
- Use the current medical literature to develop an EBM treatment plan for Irritable Bowel Syndrome.
Dyspepsia.
Upon completion of this session, the participant should be able to: EBM, COMP
- Appraise symptoms and common etiologies for dyspepsia.
- Use EBM to detect “alarm symptoms” that are suspicious for GI malignancy.
- Apply current medical evidence and expert guidelines to construct a diagnostic evaluation for Dyspepsia.
- Determine appropriate treatment for Dyspepsia based on current medical evidence and the likely etiology.
Evaluation and Treatment of Hypertensive Patients.
Upon completion of this session, using the most recent JNC Guidelines, the Cochrane Abstract Database and the evidence-based reports from Clinical Evidence, the participant should be able to: EBM, GL, COMP
- Employ the non-pharmacologic treatment options to manage hypertension.
- Specify the pharmacologic treatment options for patients with compelling indications based upon JNC Guidelines.
- Formulate the therapeutic goal for controlling blood pressure in different patient populations and the combination of medications that can achieve that goal.
- Distinguish the side effect risks for each class of antihypertensive medications.
Treating Patients with Type 2 Diabetes Mellitus.
Upon completion of this session, using the American Diabetes Association, the European Association for the Study of Diabetes Guidelines and the Cochrane Abstract Database, the participant should be able to: EBM, GL, COMP
- Evaluate the therapeutic goals in treating type 2 diabetes and their impact on morbidity and mortality.
- Recommend the approach for choosing an oral hypoglycemic agent to treat type 2 diabetes.
- Specify the clinical situations that would require the use of insulin to treat type 2 diabetes and the probable dosage form and average amounts required for control of A1c.
- Develop the therapeutic options for preventing diabetic complications.
Hyperlipidemia and CV Disease Prevention – A Review of the Literature and Recent AHA Guidelines.
Upon completion of this session, the participant should be able to: EBM, GL, COMP
- Create a diagnostic and treatment plan for patients based on the current evidence and AHA Guidelines.
- Explain similarities and differences between the most recent and previous guidelines.
- Identify areas of strength and weakness in the recent AHA Guidelines.
- Utilize the most recent cholesterol guidelines at the point of care.